IxinityCoagulation Factor IX (Recombinant)Biologic—
IxinityCoagulation Factor IX (Recombinant)Biologic—
IxinityCoagulation Factor IX (Recombinant)Biologic—
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.
Medexus Pharma — patent cliffs & loss of exclusivity | CliffBio